Nuveen Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.02M | Hold |
313,307
| – | – | ﹤0.01% | 2699 |
|
|
2024
Q3 | $1.21M | Hold |
313,307
| – | – | ﹤0.01% | 2675 |
|
|
2024
Q2 | $968K | Buy |
313,307
+19,151
| +7% | +$59.2K | ﹤0.01% | 2740 |
|
|
2024
Q1 | $759K | Hold |
294,156
| – | – | ﹤0.01% | 2813 |
|
|
2023
Q4 | $735K | Buy |
294,156
+2,134
| +0.7% | +$5.34K | ﹤0.01% | 2867 |
|
|
2023
Q3 | $593K | Sell |
292,022
-1,701
| -0.6% | -$3.45K | ﹤0.01% | 2785 |
|
|
2023
Q2 | $676K | Buy |
293,723
+19,266
| +7% | +$44.3K | ﹤0.01% | 2822 |
|
|
2023
Q1 | $832K | Sell |
274,457
-15,644
| -5% | -$47.4K | ﹤0.01% | 2670 |
|
|
2022
Q4 | $675K | Sell |
290,101
-36,039
| -11% | -$83.9K | ﹤0.01% | 2812 |
|
|
2022
Q3 | $623K | Sell |
326,140
-1,185
| -0.4% | -$2.26K | ﹤0.01% | 2904 |
|
|
2022
Q2 | $887K | Sell |
327,325
-1,278,189
| -80% | -$3.46M | ﹤0.01% | 2841 |
|
|
2022
Q1 | $4.62M | Sell |
1,605,514
-406,295
| -20% | -$1.17M | ﹤0.01% | 2103 |
|
|
2021
Q4 | $7.89M | Buy |
2,011,809
+892,198
| +80% | +$3.5M | ﹤0.01% | 1830 |
|
|
2021
Q3 | $4.87M | Buy |
1,119,611
+893,599
| +395% | +$3.89M | ﹤0.01% | 2225 |
|
|
2021
Q2 | $685K | Buy |
+226,012
| New | +$685K | ﹤0.01% | 3119 |
|